What does Rapport Therapeutics, Inc. do?
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor associated protein…
What is Rapport Therapeutics, Inc.'s P/E and P/B ratio?
Rapport Therapeutics, Inc. has a P/E ratio of -8.8 and a P/B ratio of 3.01.
What is Rapport Therapeutics, Inc.'s debt-to-equity ratio?
Rapport Therapeutics, Inc. has a debt-to-equity ratio of 0.02.
How much does Rapport Therapeutics, Inc. owe compared with what it owns?
Rapport Therapeutics, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Rapport Therapeutics, Inc.'s Positivity rank?
Rapport Therapeutics, Inc. is ranked #3,900 of 6,774 companies globally and #1,813 of 4,000 in United States on PositoAI, with a Positivity Score of 20,112.
Does Rapport Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Rapport Therapeutics, Inc..
Where can I read the latest news about Rapport Therapeutics, Inc.?
Recent headlines about Rapport Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Rapport Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Rapport Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.